Video
We discuss how microbiota could represent a resource for the development of new therapies for cancer patients with prof. Nissan Yissachar (Israel).
Antonio Gasbarrini, director of CEMAD at the Gemelli Hospital in Rome, explains how the microbiome clinics will help us against a variety of diseases.
Scott Snapper, professor at Harvard Medical School, talks about IBD and therapeutic possibilities based on the manipulation of the intestinal microbiota.
In the pathogenesis of IBDs, the gut microbiota plays a key role. Treating gut dysbiosis may be a solutions, so companies are exploring this possibility.
We asked Laurence Zitvogel about the advances in the field of oncological immunotherapy and the role of microbiome.
Ted Dinan of University College Cork, Ireland, gives us an insight into the intestine-brain axis.
